$MBX 8-K SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Effective as of October 20, 2026, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed P...
27 Aug 2026	8-K: Regulation FD Disclosure; Other Events
06 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
13 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jun 2026	8-K: Regulation FD Disclosure; Other Events
05 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
11 May 2026	8-K: Regulation FD Disclosure; Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Regulation FD Disclosure; Other Events
27 Feb 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
05 Feb 2026	8-K: Other Events
22 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
12 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
06 Nov 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
26 Sep 2025	8-K: Entry into a Material Definitive Agreement
22 Sep 2025	8-K: Regulation FD Disclosure; Other Events
04 Sep 2025	8-K: Regulation FD Disclosure; Other Events
07 Aug 2025	8-K: Results of Operations and Financial Condition
16 Jun 2025	8-K: Regulation FD Disclosure; Other Events

Comments